Am. J. Respir. Crit. Care Med., Volume 160, Number 1, July 1999, 126-131

The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children
A Dose Comparison Study

HANS BISGAARD, JOHN GILLIES, MARCELLE GROENEWALD, and CLAIRE MADEN, on behalf of an International Study Group

Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Hamilton, New Zealand; Pretoria, South Africa; and Glaxo Wellcome Research and Development, Greenford, United Kingdom

The response in asthmatic young children to inhaled steroids within the usual pediatric dose range is unknown. We therefore evaluated the dose-related response in young children with moderate asthma to inhaled fluticasone propionate (FP) (delivered via the Babyhaler spacer device) within the pediatric dose range. A total of 237 children (mean age 28 mo, range 12 to 47) with moderate asthmatic symptoms were studied in this multicenter, randomized, double-blind, parallel group, placebo-controlled study of 12 wk treatment following a 4-wk run-in period. The median use of rescue medication was 1 dose in 2 d during the run-in period. FP 50 µg twice daily (FP100) and 100 µg twice daily (FP200) was compared with placebo inhaled from a pressurized metered-dose inhaler (pMDI) and the Babyhaler spacer device. With FP200 there was a statistically significant improvement from baseline, as compared with the placebo group, in 8 of 10 diary card parameters, including the three symptom domains of wheeze, cough, and breathlessness, and use of rescue medication. FP100 produced a significant reduction in 5 of these 10 parameters, whereas no significant differences were found between the FP200 and FP100. The numbers of patients with at least one exacerbation during treatment with placebo, FP100, and FP200 were 37%, 26%, and 20%, respectively. This difference between placebo and FP200, as well as the dose-related order was significant (p < 0.05). Both FP doses were as well tolerated as placebo over the 12 wk treatment with a similar incidence of adverse effects. Asthmatic symptoms in 1- to 3-yr-old children responded in a significant and dose-related manner to treatment with FP within a pediatric dose range.

This article has been cited by other articles:

				M. Cazzola and M. Gabriella Matera Cough and asthma: the role of inhaled corticosteroids and ss2-agonists Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 7 - 11. [PDF]

				N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1304 - 1345. [Full Text] [PDF]

				T. W. Guilbert, W. J. Morgan, R. S. Zeiger, D. T. Mauger, S. J. Boehmer, S. J. Szefler, L. B. Bacharier, R. F. Lemanske Jr., R. C. Strunk, D. B. Allen, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med., May 11, 2006; 354(19): 1985 - 1997. [Abstract] [Full Text] [PDF]

				H. Bisgaard, M. N. Hermansen, L. Loland, L. B. Halkjaer, and F. Buchvald Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med., May 11, 2006; 354(19): 1998 - 2005. [Abstract] [Full Text] [PDF]

				C S Murray, G Poletti, T Kebadze, J Morris, A Woodcock, S L Johnston, and A Custovic Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children Thorax, May 1, 2006; 61(5): 376 - 382. [Abstract] [Full Text] [PDF]

				P. J. F. M. Merkus and J. C. de Jongste Inhaled Corticosteroids in Wheezy Infants Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1058 - 1059. [Full Text] [PDF]

				R. A. Silverman, K. Ito, L. Stevenson, and H. M. Hastings The Relationship of Fall School Opening and Emergency Department Asthma Visits in a Large Metropolitan Area Arch Pediatr Adolesc Med, September 1, 2005; 159(9): 818 - 823. [Abstract] [Full Text] [PDF]

				A. M. Teper, C. D. Kofman, G. A. Szulman, S. M. Vidaurreta, and A. F. Maffey Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 587 - 590. [Abstract] [Full Text] [PDF]

				W. Hofhuis, E. C. van der Wiel, E. M. Nieuwhof, W. C. J. Hop, M. J. Affourtit, F. J. Smit, A. A. P. H. Vaessen-Verberne, F. G. A. Versteegh, J. C. de Jongste, P. J. F. M. Merkus, et al. Efficacy of Fluticasone Propionate on Lung Function and Symptoms in Wheezy Infants Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 328 - 333. [Abstract] [Full Text] [PDF]

				A. Foresi, B. Mastropasqua, A. Chetta, R. D'Ippolito, R. Testi, D. Olivieri, and A. Pelucchi Step-Down Compared to Fixed-Dose Treatment With Inhaled Fluticasone Propionate in Asthma Chest, January 1, 2005; 127(1): 117 - 124. [Abstract] [Full Text] [PDF]

				H. Bisgaard, D. Allen, J. Milanowski, I. Kalev, L. Willits, and P. Davies Yes, Steroids Are Safe in Infants With Asthma-Like Symptoms Pediatrics, September 1, 2004; 114(3): 904 - 904. [Full Text] [PDF]

				H. Bisgaard, D. Allen, J. Milanowski, I. Kalev, L. Willits, and P. Davies Twelve-Month Safety and Efficacy of Inhaled Fluticasone Propionate in Children Aged 1 to 3 Years With Recurrent Wheezing Pediatrics, February 1, 2004; 113(2): e87 - 94. [Abstract] [Full Text] [PDF]

				E Verona, D Petrov, E Cserhati, J Hofman, N Geppe, H Medley, and S Hughes Fluticasone propionate in asthma: a long term dose comparison study Arch. Dis. Child., June 1, 2003; 88(6): 503 - 509. [Abstract] [Full Text] [PDF]

				H. Bisgaard A Randomized Trial of Montelukast in Respiratory Syncytial Virus Postbronchiolitis Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 379 - 383. [Abstract] [Full Text] [PDF]

				E. R Carter, H. Bisgaard, C. Maden, and N. Olsen Fluticasone vs Placebo in Toddlers With Asthma: Good Science or Questionable Ethics? Chest, December 1, 2002; 122(6): 2267 - 2268. [Full Text] [PDF]

				C. S. Pao and S. A. McKenzie Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 945 - 949. [Abstract] [Full Text]

				R. A. McIvor Pharmacoeconomics in Pediatric Asthma Chest, December 1, 2001; 120(6): 1762 - 1763. [Full Text] [PDF]

				H. Bisgaard, M. J. Price, C. Maden, and N. A. Olsen Cost-Effectiveness of Fluticasone Propionate Administered Via Metered-Dose Inhaler Plus BabyhalerTM Spacer in the Treatment of Asthma in Preschool-Aged Children Chest, December 1, 2001; 120(6): 1835 - 1842. [Abstract] [Full Text] [PDF]

				M. J. VISSER, D. S. POSTMA, L. R. ARENDS, T. W. DE VRIES, E. J. DUIVERMAN, and P. L. P. BRAND One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma . Effects on Hyperresponsiveness, Lung Function, and Height Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2073 - 2077. [Abstract] [Full Text] [PDF]

				B. Knorr, L. M. Franchi, H. Bisgaard, J. H. Vermeulen, P. LeSouef, N. Santanello, T. M. Michele, T. F. Reiss, H. H. Nguyen, and D. L. Bratton Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years Pediatrics, September 1, 2001; 108(3): e48 - 48. [Abstract] [Full Text] [PDF]

				R J Chavasse, Y Bastian-Lee, H Richter, T Hilliard, P Seddon, and G. RUSSELL Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone Arch. Dis. Child., August 1, 2001; 85(2): 143 - 148. [Abstract] [Full Text] [PDF]

				H. Bisgaard Persistent Wheezing in Very Young Preschool Children Reflects Lower Respiratory Inflammation Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1290 - 1291. [Full Text]

				B. J. Lipworth, C. M. Jackson, M. H. Mellon, and J. Leflein COMPARABLE EFFICACY OF ADMINISTRATION WITH FACE MASK OR MOUTHPIECE OF NEBULIZED BUDESONIDE SUSPENSION FOR INFANTS AND YOUNG CHILDREN WITH PERSISTANT ASTHMA Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1277a - 1278. [Full Text]

				H. Bisgaard Leukotriene Modifiers in Pediatric Asthma Management Pediatrics, February 1, 2001; 107(2): 381 - 390. [Abstract] [Full Text]

				Other articles noted Evid. Based Nurs., October 1, 2000; 3(4): 106 - 112. [Full Text]

				K. G. NIELSEN and H. BISGAARD The Effect of Inhaled Budesonide on Symptoms, Lung Function, and Cold Air and Methacholine Responsiveness in 2- to 5-year-old Asthmatic Children Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1500 - 1506. [Abstract] [Full Text] [PDF]

				H. BISGAARD and K. G. NIELSEN Bronchoprotection with a Leukotriene Receptor Antagonist in Asthmatic Preschool Children Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 187 - 190. [Abstract] [Full Text]